| 1Thalidomide |
|---|
| 2Thalidomide |
Compound Name Thalidomide |
CID 5426 |
Molecular Formula C13H10N2O4 |
Molecular Weight 258 |
No. Chiral Centers: 1 |
No. Hydrogen Bond Acceptors 4 |
No. Hydrogen Bond Donors 1 |
Applications
Lux i-Amylose-3 Separation for Thalidomide
25342
Separation Mode: Chiral
Chiral
i-Amylose-3
HPLC
Angiogenesis Inhibitors
Pharmaceutical/Biopharmaceutical
Therapeutic / Clinical
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 25342)
Column: | ||||||
Brand Name: | ||||||
Part No: | ||||||
Phase Name: i-Amylose-3 | ||||||
Elution Type: Isocratic | ||||||
Mobile Phase: A: Acetonitrile B: Diethylamine | ||||||
Gradient Profile:
| ||||||
Flow Rate: 1 mL/min | ||||||
Temperature: 25°C | ||||||
System: Agilent Technologies Agilent Technologies | ||||||
Detection: LC/UV (DAD, PDA) @ 254.0000000000 nm (nanometers) | ||||||
Sample Note: 2 mg/mL in Ethanol |
Order Items Used in This Application
00G-4779-E0
Lux 5 µm i-Amylose-3, LC Column 250 x 4.6 mm, Ea
Qty:
Similar Applications
search
Thalidomide
Lux 5 µm i-Cellulose-5, LC Column 250 x 4.6 mm, EA
Chiral
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
